Finding accredited CPD
Pharmaceutical companies have an environmental impact in terms of waste generation and disposal, greenhouse gas emissions, air pollution, and water, plastic, and energy consumption. In Australia, the pharmaceutical industry is responsible for about 19% of greenhouse gas emissions in the health care sector, and receives about 16% of government spending on health, principally through Pharmaceutical Benefits Scheme (PBS) subsidies (2022–23: $16.7 billion).
The 2015 United Nations Paris Agreement required countries to begin reporting and reducing carbon emissions. Several international protocols standardise monitoring and reporting, set science‐based emissions reduction targets, and promote accountability and measurable outcomes. Standards improve sustainability disclosure and complement rather than substitute for each other. Under the Greenhouse Gas Protocol, emissions are categorised as scope 1, 2, and 3 emissions.
This MJA Research shares more.
Authors: Hayden Burch, Georgia Brown, Oliver Adler, Jason Wong and Kenneth D Winkel
Article Type: Research
You have to log in to see the content of this module.
Provided by
Accepted by
*Medical Board of Australia’s (MBA)’s revised Registration Standard: Continuing professional development (the Standard)
